To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)
Clinical trial NCT04606329 · COMPLETED
Trial details
- NCT number
- NCT04606329
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2021-01-28
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.